Skip to main content

Table 2 Demographical and clinical characteristics of SPMS patients

From: Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

 

Treated IFN transcriptional responders

Treated IFN transcriptional non responders

Untreated

N

12

8

30

Age (years)

52.4 ± 2.8

54.9 ± 1.5

51.3 ± 1.4

F (M)

10 (2)

6 (2)

18 (12)

Disease duration (years)

12.9 ± 2.1(*)(**)

22.3 ± 2.8

19.0 ± 1.5

EDSS

6.3 ± 0.2(**)

6.3 ± 0.3

7.2 ± 0.1

Time to EDSS 6 (years)

11.4 ± 2.0

13.5 ± 1.4

12.6 ± 1.3

Annual EDSS change

0.6 ± 0.1(*)

0.3 ± 0.1

0.4 ± 0.1

Relapse rate

0.8 ± 0.1(*)(**)

0.4 ± 0.04

0.4 ± 0.05

Treatment duration (years)

3.5 ± 0.8(*)

6.4 ± 1.2

NA

  1. *p <0.05 between SPMS transcriptional responders vs. non-responders
  2. **p < 0.05 between SPMS transcriptional responders vs. untreated